Use access key #2 to skip to page content.
$50.91 -0.03 (-0.06%)
5/16/2008 4:00 PM

LifeCell Corp (LIFC)

CAPS Rating:
****

The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

View All Commentary (LIFC)

Recs

0

Avatar spartanfox (85.03) Submitted: 5/06/08 5:10 PM : Outperform Start Price: $50.71 LIFC Score: -0.10

The healthcare industry is primed to rise as both the baby-boomers and significant advances in medicine take hold. The stock is trading at the high point of the 52 week range, but it is liable to continue rising.

Report this Post Replies: 0 | Reply

Featured Broker Partners